CORT Jul 2024 29.000 put
| Previous close | 6.20 |
| Open | 6.20 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 29.00 |
| Expiry date | 2024-07-19 |
| Day's range | 6.20 - 6.20 |
| Contract range | N/A |
| Volume | |
| Open interest | 44 |
Simply Wall St.Insider-Owned Growth Companies To Watch On US Exchanges In June 2024
As of June 2024, the U.S. stock market exhibits a cautious tone, with investors weighing the implications of recent Treasury auctions and Federal Reserve decisions amidst ongoing political uncertainties in Europe. In such a market environment, growth companies with high insider ownership can be particularly noteworthy as these insiders may have a vested interest in the company's long-term success, potentially aligning their goals closely with those of external shareholders.
ZacksWhy Is Pacira (PCRX) Up 1.7% Since Last Earnings Report?
Pacira (PCRX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
GuruFocus.comInsider Sale: Chief Development Officer William Guyer Sells 10,000 Shares of Corcept ...
On June 3, 2024, William Guyer, the Chief Development Officer of Corcept Therapeutics Inc (NASDAQ:CORT), sold 10,000 shares of the company at a price of $32 per share.
